Tuberculosis presents an ongoing global health challenge, disproportionately affecting the most vulnerable members of the population in countries around the world. Janssen Pharmaceutica is committed to meeting this challenge, and providing a solution to those who are most affected. To do this, it’s vital to partner with the governmental, academic and advocacy organizations who are able to effect real change. Janssen is working in collaboration with several major partners, including USAID, The Union and Pharmstandard. Together, Janssen and these organizations are taking major steps towards ending TB.